Literature DB >> 18444821

The importance of the group a streptococcus capsule in the pathogenesis of human infections: a historical perspective.

Gene H Stollerman1, James B Dale.   

Abstract

The virulence of group A streptococci (GAS) correlates closely with expression of its surface antigen, M protein, and its hyaluronic acid capsule. In studies of human GAS infection, the former has received considerable attention. For several decades, however, systematic identification of encapsulated virulent strains by the mucoid colonies they produce has been neglected in clinical studies. In part, this may be due to the capsule's evanescent expression on artificial media, its repression during convalescent carriage, lack of expertise in recognizing its colonial morphology, and the growing tendency for clinical laboratories to eschew throat cultures in favor of rapid laboratory tests for group A polysaccharide. Older and more recent studies are reviewed here that emphasize the capsule's basic role in infection. We believe that it is time to refocus newer clinical studies and techniques on achieving early recognition of potentially dangerous, heavily encapsulated strains of GAS for which spread may be prevented.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18444821     DOI: 10.1086/529194

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  34 in total

1.  To be capsulated or not be capsulated: that is the GAS question.

Authors:  Roberta Creti; Giovanni Gherardi; Monica Imperi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-08-13       Impact factor: 3.267

2.  Group A Streptococcal Virulence: New Lessons.

Authors:  Stanford T Shulman; James B Dale
Journal:  J Pediatric Infect Dis Soc       Date:  2019-05-11       Impact factor: 3.164

Review 3.  Molecular insight into invasive group A streptococcal disease.

Authors:  Jason N Cole; Timothy C Barnett; Victor Nizet; Mark J Walker
Journal:  Nat Rev Microbiol       Date:  2011-09-16       Impact factor: 60.633

Review 4.  Group A Streptococcus encounters with host macrophages.

Authors:  J Andrés Valderrama; Victor Nizet
Journal:  Future Microbiol       Date:  2017-12-11       Impact factor: 3.165

5.  An antibody profile of systemic lupus erythematosus detected by antigen microarray.

Authors:  Ittai Fattal; Noam Shental; Dror Mevorach; Juan-Manuel Anaya; Avi Livneh; Pnina Langevitz; Gisele Zandman-Goddard; Rachel Pauzner; Miriam Lerner; Miri Blank; Maria-Eugenia Hincapie; Uzi Gafter; Yaakov Naparstek; Yehuda Shoenfeld; Eytan Domany; Irun R Cohen
Journal:  Immunology       Date:  2010-02-26       Impact factor: 7.397

6.  Titan cell production enhances the virulence of Cryptococcus neoformans.

Authors:  Juliet N Crabtree; Laura H Okagaki; Darin L Wiesner; Anna K Strain; Judith N Nielsen; Kirsten Nielsen
Journal:  Infect Immun       Date:  2012-08-13       Impact factor: 3.441

7.  Mapping the protein-protein interface between a toxin and its cognate antitoxin from the bacterial pathogen Streptococcus pyogenes.

Authors:  Justin B Sperry; Craig L Smith; Michael G Caparon; Tom Ellenberger; Michael L Gross
Journal:  Biochemistry       Date:  2011-04-19       Impact factor: 3.162

8.  Wiring the streptococcal network for alternative lifestyles.

Authors:  Debra E Bessen; Farah K Tengra
Journal:  J Infect Dis       Date:  2010-03-15       Impact factor: 5.226

9.  Serotype- and strain- dependent contribution of the sensor kinase CovS of the CovRS two-component system to Streptococcus pyogenes pathogenesis.

Authors:  Venelina Sugareva; Regina Arlt; Tomas Fiedler; Catur Riani; Andreas Podbielski; Bernd Kreikemeyer
Journal:  BMC Microbiol       Date:  2010-02-01       Impact factor: 3.605

10.  A conserved UDP-glucose dehydrogenase encoded outside the hasABC operon contributes to capsule biogenesis in group A Streptococcus.

Authors:  Jason N Cole; Ramy K Aziz; Kirsten Kuipers; Anjuli M Timmer; Victor Nizet; Nina M van Sorge
Journal:  J Bacteriol       Date:  2012-09-07       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.